Increased incidence of cancers and the development of totally implanted venous access
devices that contain their own port to deliver chemotherapy will lead to a greater than before …

Objectives Increased incidence of cancers and the development of totally implanted venous
access devices that contain their own port to deliver chemotherapy will lead to a greater than …

Central venous catheters (CVCs) have improved the management of patients with cancer
substantially, by facilitating chemotherapy and supportive therapy. The use of CVCs is …

Symptomatic catheter related thrombosis (CRT) occurs in 4%–8% of cancer patients. The
mean incidence of CRT, detected either by echography or Doppler ranges between 12 and …

Long-term central venous catheters (CVCs) have considerably improved the management of
cancer patients because they facilitate chemotherapy, transfusions, parenteral nutrition, and …

Patients with cancer are at high risk for developing venous thromboembolism (VTE), and the
presence of a central venous catheter (CVC) further increases this risk. CVC-related VTE …

Central venous catheters (CVC) play an essential role in the management of cancer
patients. Venous thrombosis is a common complication of CVC. The incidence of CVC …

The use of long-term central venous catheters (CVC) has considerably facilitated the
administration of chemo-and supportive therapy in cancer patients. However, despite this …

Objectives: Central venous access is needed to facilitate chemotherapy for many cancer
patients. Central venous catheter-related thrombosis (CVCT) is a major complication that …

Venous thromboembolism (VTE) occurs frequently in patients with hemato-oncological
diseases and is one of the leading causes of death [1]. The risk for developing VTE may be …